FDA Weakens Rules on Testing New Drugs_LA Times
FDA is speeding the testing of unknown, potentially toxic products in humans (Phase I trials) without adequate pre-human tests.
-
-
Psych drug Rx for teens surge 250% over seven years_Brandeis
A Brandeis University study reviewed clinical practice (doctor office visits) and found that drug prescriptions for the treatment of depression, anxiety and mood or attention disorders in teenagers (14 to 18) increased by 250% between 1994-2001.
-
Cloning Scam: Dr. Gerald Schatten’s Hand in Bogus Paper Detailed
In this era of commercially-driven medical research—whether conducted by industry or academia—it behooves journal editors—no matter how prestigious the authors submitting articles for publication—to at least follow Ronald Reagan’s dictum, “trust but verify.”
-
FDA rules aim to speed drug tests and trim costs
The Food and Drug Administration yesterday issued new guidelines that make it easier for scientists working in universities and small companies to test promising therapies in humans without matching the hefty spending of large drug companies.
-
ACNP Task Force Ties to Pharma
Authors of the American College of Neuropsychopharmacology Task Force on SSRIs and Suicidal Behavior in Youth: their known ties to the pharmaceutical industry
-
Chief Respiratory Care Mass General Hospital-Harvard-Rejects ARDS Recommendation
A critical editorial by Dr. Robert M Kacmarek, Head of Respiratory Care Services at Massachusetts General Hospital and professor at Harvard University—the coordinating center for the ARDS Network, calls into question the validity of the ARDS Network recommendation of treating all patients with ALI-ARDS with a fixed, low air ventilation setting (6 mL/ kg).
-
Unhealthy Medicine-Wash Post_Drug Profits Infect Medical Studies–LA Times
”SO WHY,” he asks, “DID American doctors prescribe $7 billion worth of Vioxx after Merck and the Food and Drug Administration knew all this?”
-
FDA: NIMH SSRI Study Flawed–No Comparative Untreated Group
Even Dr. Robet Temple, FDA Medical Policy Director of the Center for Drug Evaluation & Research dismisses the claimed finidings of a flawed, but highly trumpeted recent SSRI study published in the American Journal of Psychiatry. The study was sponsored by the National Institute of Mental Health.
-
Newsflash 4
“First they ignore you, then they laugh at you, then they fight you, then you win.” – Mahatma Gandhi
-
J & J Failed to Disclose Deaths in Heart Trial
"When you’re talking deaths in clinical trials, mistakes are not an option," said Dr. Arthur Caplan, a medical ethicist at the University of Pennsylvania. "It’s just an area where we have to have absolute, foolproof reporting in place."
-
Surgery Journal to Ban Authors Who Fail to Disclose Conflicts of Interest
"With conflicts of interest increasingly casting doubt on the credibility of medical research, a leading surgery journal is cracking down on authors who fail to disclose links to industry, threatening to temporarily blacklist them."
-
Pharma front ACSH: “Whiny Whistleblower of the Year Award”
2005 was a year in which some of Big Pharma’s clandestine relationships with an army of bought-and- paid- for minions in academia,
government, congress, the media, and front organizations were uncovered–in courtrooms, investigative books, reports and films.